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THESIS SUMMARY
The aim of this thesis is to investigate the effect of physical activity and the administration of
s-equol on rates of neurogenesis in HIV-1 transgenic rats. HIV-1 is a neurodegenerative disease that
leads to the wide range of cognitive impairment described as HAND. Neurogenesis is a newly
discovered process that involves the birth of new neurons during our adult life within the dentate
gyrus of the hippocampus. Therefore, inducing neurogenesis may be a proper therapeutic that can
mitigate some of the cognitive destruction seen as a result of HIV-1 infection. Physical activity has
shown to increase the rate of neurogenesis by activating BDNF proteins that stimulate brain
plasticity. We used wheel running to investigate if physical activity may increase neurogenesis in our
HIV-1 infected rat. S-equol has shown restorative and protective benefits for neurons. We hoped that
oral doses of s-equol pellets could assist young neurons in maturation and thus, assist in successful
neurogenesis. To investigate rates of neurogenesis, we used immunohistochemical techniques to stain
for the doublecortin protein, which exists in neurons as they migrate between 2 and 8 weeks after
birth. Tagging these proteins would indicate recent birth of neurons as a result of our experimental
condition. The results indicate only a few significant effects from the introduction of physical activity
and s-equol. In our rodents exposed to physical activity, we found significant effects on total counts
suggesting that males grow more neurons than females, and on location of recently grown neurons
with more cell counts on the ventral blade of the dentate gyrus. For animals introduced to s-equol, we
found significant effects in the F344 control animals suggesting that s-equol treatment increases rates
of neurogenesis in the dorsal blade of the dentate gyrus, and an interaction between location of
neurons and treatment group. Between the two experiments, we did not find a significant effect of
physical activity or s-equol on increasing neurogenesis in the HIV-1 transgenic animals.
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It is estimated that 37.9 million people worldwide are infected with HIV (HIV Basics,
2019). The neurodegenerative disease impairs the immune system leading to a wide range of
bodily impairment. It is the interest of this thesis to study cognitive impairment associated with
HIV-1 and investigate the role that neurogenesis can play in reversing the neurodegenerative
effects of the virus. Neurogenesis refers to the process of growing new neurons after birth which
may mitigate the cognitive symptoms associated with HIV-1.
Introduction
HIV-1
The Human Immunodeficiency Virus-1 (HIV-1) is transmitted through contact with an
infected individual’s bodily fluid. This can come in the form of blood, semen, rectal fluids,
vaginal fluids, or breast milk (How is HIV Transmitted, 2019). This infectious bodily fluid is
then absorbed into the bystander’s bloodstream and the virus begins to replicate through the
individual. The most common forms of transmission come through sexual intercourse and
penetrating wounds such as needles or cuts. HIV-1 cannot be transmitted through the air, insects,
or body contact; the HIV-negative individual must absorb the virus through their bloodstream.
After transmission, the virus infects white blood cells, wrecking the immune system. As
the immune system weakens, the HIV+ individual becomes much more susceptible to common
germs and illnesses leading to weakness. There are treatments to boost the immune system, as
will be discussed later, but no reliable cure has been developed to completely wipe out the virus.
HIV-1 leads to impairment by infecting the CD4 T-cells of the immune system (HIV: The
Basics, n.d.). The virus enters these white blood cells, replicates, destroys the cell, and then
moves to other CD4 cells. As the virus continues to replicate it spreads throughout the body and
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destroys more cells. Of course, the immune system tries to create more CD4 cells to fight the
virus, but there is no hope as the virus continues to replicate and expand. Once the CD4 count
drops below 200/mm3, the patient is officially diagnosed with AIDS. Studies show that a lower
CD4 count directly correlates with the severity of cognitive impairment. Ronald Ellis and
colleagues (2011) found that HIV infected patients with a low CD4 nadir, or the historically
lowest cell count, were much more likely to develop severe cognitive impairment. This result
indicates that the sooner treatment begins, the greater the CD4 nadir, and the less severe
neuropsychological impairment found in the patient. Therefore, infection of the HIV virus
suppresses the immune system by destroying CD4 cells.
Due to the complexity of HIV-1 there are several other ways the virus can lead to
cognitive impairment. These include inflammation and infection of monocytes/macrophages in
the brain. According to research by Shibani Mukerji, it only takes a few days for HIV-1 to be
detected in the cerebrospinal fluid after the virus has been transmitted into the bloodstream
(Castles, 2017). Once the cerebrospinal fluid carries the disease directly into the brain,
inflammatory processes release chemokines and cytokines to combat the virus. Some of these
toxins are neuroprotective, but others are neurotoxic (Elbirt et al., 2015). These neurotoxins
infect the neuroprotective astrocytes which can lead to cell death and destruction of the bloodbrain-barrier. As a result, the inflammatory process indirectly destroys neurons leading to
neurocognitive impairment. The inflammation also recruits more immune cells to the area of
infection, which inevitably become overtaken by HIV-1 (Castles, 2017). Mukerji finds that after
only a few days post-infection, the virus can decrease brain size and destroy neural networks.
Other research shows that infection of monocytes and macrophages can lead the virus through
the blood-brain-barrier and cause direct neurocognitive impairment (Elbirt et al., 2015). Once a
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monocyte becomes infected and crosses the blood-brain-barrier it will turn into a macrophage.
These macrophages can release viral proteins like gp120, Tat, and Vpr which latch onto neurons
prompting neuronal death. Therefore, neurotoxins and proteins released as a result of
inflammation and infected macrophages lead to neuronal death.
The means by which HIV-1 causes neurocognitive impairment is through the destruction
of neurons and other support cells found in the brain. Although we do not fully understand the
mechanisms leading to neurodegeneration, some studies have investigated components that lead
to the destruction of cells in the central nervous system. As mentioned previously, this
neurodegeneration is a result of inflammation and macrophages releasing neurotoxins, harming
the neighboring cells. Macrophages and other elements of the immune system may also interact
causing impairment. The chemokine stromal cell-derived factor 1α (SDF-1) is released from
astrocytes to fight HIV-1 infection in the brain (Zhang et al., 2003). At the same time,
macrophages release the enzyme zymogen matrix metalloproteinase-2 (MMP-2) which interfere
with SDF-1 and alter the protein’s structure. This creates a neurotoxic protein leading to
neuronal apoptosis and greater inflammation. A cycle is created as greater inflammation causes
the release of more cytokines which activate astrocytes to release SDF-1 reacting with more
MMP-2. As a result, two proteins trying to fight HIV can alter shape and create a neurotoxin that
creates greater atrophy in the brain.
In addition, viral products like gp120 can lead to neurodegeneration due to HIV-1
infection. The glycoprotein is found on the outside surface of the HIV envelope and fuses with
an unaffected immune cell allowing the virus to pass into the new host cell. The direct pathway
passes the virus into the unaffected cell leading to further replication and eventually cell death.
Though HIV cannot directly infect neurons, the overall damage the virus causes to support cells
3
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causes changes in neuronal structure. Studies show that gp120 leads to dendritic alterations,
increased interleukin-1 activation, astrocytosis, and alterations in calcium levels (Masliah, Ge,
Mucke, 1996). Other evidence indicates that gp120 released from infected cells can enter
neurons and fragment mitochondria leading to expected expulsion of the organelle from the
neuron (Teodorof-Diedrich and Spector, 2018). However, gp120 also alters the process of
mitophagy causing a failure to clear the damaged mitochondria. This results in neuronal damage
and can lead to neurodegenerative impairment. Furthermore, gp120 is shown to increase the
production of ceramide within neurons (Jana and Pahan, 2004). Ceramide is a vital ingredient in
activating apoptosis, thus, gp120 may mediate programmed neuronal cell death. Therefore, viral
protein gp120 can lead to significant impairment by spreading the HIV virus to immune cells and
by directly infiltrating and damaging neurons.
Other proteins, such as p53, play a distinct role in neurons and can be altered due to HIV1 neurotoxins like gp120 and Vpr. P53 is known to control processes such as cell cycles, DNA
repair, metabolic adaptation, and cell death (Aubrey, Kelly, and Janic, 2018). The protein plays a
major part in tumor prevention and regulates the transcription of about 500 genes. A study shows
that the introduction of gp120 increases the amount of p53 activation in neurons and microglia
which stimulate the respective cells death (Garden et al., 2004). P53 is necessary for gp120 to
show its neurotoxic effects, without which, neurons were resistant to harm due to the addition of
gp120. Furthermore, the same study found that p53 levels were higher in HIV-1 infected tissue
compared to controls. This indicates that p53 may play a specific role in programmed cell death
and the neurodegeneration resulting from the HIV-1 virus. A separate experiment investigated
the role that Viral Protein R (Vpr) plays in p53-mediated cell death (Jones et al., 2007). Vpr is an
accessory protein used to replicate HIV-1 within a macrophage. The study found similar results
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to gp120, as elevated levels of Vpr increased activation of p53. This activation could be due to
extra stress caused by Vpr, increased transcription of p53 due to Vpr, or disruption of p53
regulators from Vpr. Another study showed that Vpr may also destroy mitochondrial
membranes, cause astrocyte apoptosis, and increase caspase-6 activation leading to cell damage
(Noorbakhsh, 2010). Therefore, both gp120 and Vpr act as neurotoxins and play a role in the
activation of p53 which effects cell cycles and may promote neurodegeneration.
Not all HIV-mediated neurodegeneration happens evenly across the brain. One study
used postmortem data to conclude that hippocampus and putamen atrophy predicted level of
neuropsychological impairment (Moore, 2006). These regions are notorious for their
involvement in memory and movement. More neurodegeneration correlated with the amount of
HIV-1 antigen found within the brain circuitry of the limbic system and basal ganglia, which also
play a role in higher cognitive function and movement (Masliah, Ge, Mucke, 1996). However,
the virus certainly does not target specific areas and can be found throughout the cortex leading
to a wide range of cognitive deficits.
The previous paragraphs have focused on how HIV-1 infects the brain and leads to
neurodegeneration. After entering the bloodstream and penetrating the blood-brain-barrier, the
virus begins to send neurotoxins throughout the brain. The disease continuously replicates and
slowly tears the brain apart. The following paragraphs examine the cognitive deficits as a result
of this neurodegeneration and the different types of HIV impairment that can form as a result of
the damage.
The destruction caused by HIV is widespread and various throughout the brain. This
results in cognitive deficits such as depression, delirium, and dementia (Watkins and Treisman,
2015). HIV is known to infect the subcortical areas of the brain that control mood, stress, and
5
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behavior. The combination of this neurodegeneration and the social stigma attached with being
an individual with HIV may be the cause of depression rates as high as 40% in HIV-1 patients
(Watkins and Treisman, 2012). Other evidence suggests that depression rates increased by 250%
as patient’s CD4 cell counts dropped to less than 200/mm3, qualifying the patient as having
AIDS (Changes in depressive symptoms as AIDS develops, 1996). Whether due to biological
factors or social constructs, there is no doubt that HIV-1 leads to depressive symptoms. The
disease can also cause delirium leading to disorganized thoughts, failure to focus, and unstable
consciousness. 30%-40% of AIDS patients suffer from delirium (Perry and Morotta, 1987). This
impairment is the consequence of immune deficiencies associated with HIV-1, as patients are
vulnerable to cardiovascular diseases, deficiencies in blood metabolites, and other psychotic
disorders. Finally, HIV patients suffer from memory loss, failure to problem-solve, and inability
to use language as they gain symptoms of dementia. Patients suffer from minor cognitive-motor
disorder in the initial stage of HIV-1 infection, which can expand into HIV-Associated-Dementia
as symptoms worsen. Dementia is found in 60% of AIDS patients causing failure in executive
functioning and motor control (Sevigny et al., 2004). Therefore, research indicates cognitive
deficits as a result of HIV-1 infection that lead to depression, delirium, and dementia.
The summarization of this impairment has been termed HIV-Associated-NeurocognitiveDisorders (HAND). Antiretroviral treatments have significantly increased survival rates by
decreasing the amount of HIV-1 in the bloodstream, yet there is still a large population who lives
with HAND. Once cognitive deficits were associated with AIDS, research groups such as the
NIH and American Academy of Neurology looked to classify the symptoms of HAND (Woods
et al., 2009). They found that slowed movement and slowed information processing form the
cornerstones of the HAND diagnosis (Hardy and Hinkin, 2002). HAND also considers failure in
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memory. Episodic memory can become impaired as the result of neurodegeneration in the
frontostriatal loop (Castelo et al., 2006) and inefficient encoding (Morgan et al., 2009).
Prospective memory, or the ability to execute future intentions, is also damaged as a result of
deficits in strategic encoding and retrieval of the intention (Carey et al., 2006). HAND also lists
attention deficiency as a symptom predicted by the severity of HIV-1 infection. Attention deficits
are found in divided attention (Hinkin, Castellon, and Hardy, 2000), orienting (Martin et al.,
1995), and response inhibition (Hinkin, Castellon, and Hardy, 1999) as a result of HIV-1
infection. Furthermore, as the demands of each of these tasks increase, the attentional deficits
seem more profound. HAND also leads to executive dysfunction leading to impairments in
everyday processing. Destruction of prefrontal regions and the basal ganglia may play a role in
the poor event sequencing (Melrose et al., 2008), while neurodegeneration in posterior parietal
cortex and the dorsolateral prefrontal system affects tasks requiring abstraction, problem solving,
and reasoning (Struss and Levine, 2002). Most data suggest that HAND patients still have
functioning visuoperception, language, and speech capability, though these results vary and need
to be further explored (Woods et al., 2009). These deficits are likely the result of
neurodegeneration and destruction from the HIV-1 virus, yet some research suggests that
synaptic damage is the main cause of neurocognitive deficiency (Ellis, Langford, and Masliah,
2007). The impairments have been classified together to form HAND and cause excessive
cognitive dysfunction.
The deficits from HAND have also been captured from neuroimaging technologies.
Diffusion Tensor Imaging shows excessive volume loss in brain regions of HIV+ individuals.
Volume deficits are seen in the basal ganglia, posterior cortex, and white matter tracts throughout
the brain (Magnetic resonance imaging measurement…, 1995). Meanwhile, the volume of the
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third ventricle is more likely to become enlarged due to the loss of brain volume (Ragin et al.,
2012). The greatest volume loss was seen in patients with severe HAND, which predict poorer
cognitive performance (Stout, 1998). Functional Magnetic Resonance Imaging shows greater
blood flow to the frontal and parietal regions compared to controls during attention tasks
indicating difficulty of the task for HIV+ individuals (Chang et al., 2001). The scans also show
deficits in the frontostriatal network, specifically in the frontal gyrus and caudate nucleus, which
lead to impairments in movement and cognition (Du Plessis, 2014). Positron Emission
Tomography indicates that HIV+ individuals have a lower cerebral metabolic rate for glucose
consumption (Pascal et al., 1991) and hypometabolism in frontal lobes (Anderson et al., 2006).
The scans also show deficiency in dopamine transporters in the putamen, ventral striatum, and
caudate suggesting HIV’s destruction of dopaminergic nerve terminals (Wang et al., 2004).
Taken together, multiple brain imaging technologies can shed insight into the various
impairment caused from HIV-1 infection. The deficiencies are highlighted by loss of cortex
volume, change in blood flow, poor metabolic rates, and destruction of the dopaminergic system.
Most of the damage is reflective of the levels of neurodegeneration and neurotoxicity associated
with the virus. Therefore, brain scans have become useful in displaying the destruction from
HIV-1 and help to indicate how future treatment can prevent these damages.
Although there is no consistent cure to HIV, antiretroviral therapy (ART) have been
introduced to control the infection. ART lowers the viral load which halts further HIV-1
impairment. By reducing the viral load, HIV-1 treatment hopes to prevent replication of the
virus, increase CD4 cell counts to boost the immune system, and inhibit transmission of the
disease to others. However, as soon as the patient stops taking ART medication, the
consequences of HIV-1 will return. It is recommended an infected individual begins receiving
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treatment as soon as possible to prevent further cognitive decline. After treating HAND patients
with ART, neuropsychological impairment decreased as early as 12 weeks after treatment and
improvement was found in 40% of patients (Cysique, 2009). ART allows most HIV+ individuals
to live improved lives, but it is not perfect and needs to be expanded to counteract the mild
impairment from the HIV virus.
The previous paragraphs have laid an extensive outline of HIV-1. After transmission, the
virus moves through the blood into the brain where it infects macrophages. Inflammation of the
brain leads to indirect damage to the immune system, while release of neurotoxins like gp120
and Vpr can lead directly to neurocognitive impairment. Neurodegeneration of cells supporting
brain processes incite damage in executive function like memory and movement, the effects of
which have been labeled HAND. ART decreases the viral load which minimizes the impairment
due to HIV infection, but mild forms of the disease still cause some neuropsychological
impairment. Therefore, HIV-1 persists as a prominent disease and further treatments needs to be
examined.
NEUROGENESIS
Neurogenesis refers to the process of growing new neurons after the individual is born.
This counters old thought which suggested that humans are born with the maximum number of
neurons, and they only lose neurons during adult life. New neurons originate as progenitor cells
found in the subgranular zone (SGZ) of the dentate gyrus, a region of the hippocampus (Kuhn,
Dickinson-Anson, and Gage, 1996). The new neurons then migrate into the granular zone and
begin to differentiate into functioning neurons. Neurogenesis is also demonstrated in the
subventricular zone, but for the purpose of this experiment we will only investigate the SGZ. The
following sections examine the cellular mechanisms leading to neurogenesis, functional role of
9
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neurogenesis in cognition, how physical activity and hormones may spur the growth of neurons,
and the procedures used by HIV-1 to impair neurogenesis.
Gotz and Huttner provide a comprehensive review on the cell biology involved in
neurogenesis (2005). As with most cells, neurons originate as self-renewed and multipotent stem
cells. Stem cells found within the central nervous system are known as neuroepithelial cells that
will further divide to form radial glial cells. Radial glial cells migrate to the SGZ and have the
potential to differentiate into many cells found in the brain such as astrocytes, oligodendrocytes,
or neurons. Radial glial cells bound to become neurons further divide into D cells resting within
the SGZ (Seri et al., 2001). D cells continue to divide, develop, and migrate through the SGZ
toward the granule layer (Seri et al., 2004). By the time D cells have traveled to the SGZ-granule
layer border they are considered young neurons with a distinct soma, dendritic arbor, and axon
that will synapse with the CA3 region of the hippocampus. As the neurons mature, they continue
to grow and migrate further into the granule cell layer of the dentate gyrus (Seri et al., 2004). It is
estimated that about 700 functional neurons are added to each hippocampus every day (Dhaliwal
and Lagace, 2011). Therefore, stem cells have the potential to proliferate and differentiate from
the radial glial progenitor cell to fully functional neurons.
It is not fully understood why neurogenesis is useful for higher cognition, yet some
theories propose the process is useful for learning, memory, and forgetting. A review by Yau,
Li, and So examine how these processes relate to neurogenesis in the hippocampus (2015).
Findings indicate that new neurons are able to influence encoding and behavior of other mature
neurons (Ming and Song, 2011). New neurons can be activated by environmental stimuli
(Ramirez-Amaya et al., 2006), inhibit existing neuronal circuits (Acsady et al., 1998), and
compete for synaptic contact (Toni and Sultan, 2011). Studies that examine the relationship of
10
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neurogenesis with learning and memory find that an increase in adult-born neurons lead to better
results on the Morris Water Maze spatial memory task (Nilsson et al., 1999), startle reflex tasks
(Iso, Simoda, and Matsuyama, 2007), and long term potentiation in the CA1 region (van Praag et
al., 1999). Studies that have inhibited hippocampal neurogenesis have found deficits in memory
formation (Jaako-Movits et al., 2005), memory retrieval (Kee et al., 2007), and reference
memory in the Morris Water Maze task (Lemaire et al., 2000). Much of this data suggests that
newly formed neurons are used to form relationships between environmental stimuli by helping
to distinguish between similar cues (Tronel, 2012) allowing the individual to navigate the
surrounding space and enhance learning discrimination (Baker, 2003). Although there is clear
evidence suggesting neurogenesis assists in learning and memory, other studies have investigated
how the creation of new neurons may be vital in the process of forgetting. Through proactive
interference, neurogenesis provides the means to extinguish existing memories that conflict with
the current understanding (Epp, Silva-Mera, and Kohler, 2016). In addition, by inhibiting
neurogenesis, encoded memories become more stable preventing the clearance of old memories.
Promoting neurogenesis accelerates this clearance of encoded memories as new neuronal
connections take the place of old connections (Deisseroth et al., 2004). One study even shows
that promoting neurogenesis after fear-conditioning an animal leads to extinction of the fear as
the animal forgets the association with the stimulus when the growth of new neuronal
connections replaces the original fear (Holden et al., 2012). Therefore, neurogenesis plays a vital
role in memory by distinguishing environmental cues and overtaking similar memories. The
creation of adult-born neurons promotes higher cognition through both learning and forgetting
processes.
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Previous paragraphs have focused on the procedures and impacts of neurogenesis. There
are several techniques that can spur the growth of neurons, but for the sake of improving HIV-1
impairment, we will only focus on the effects of physical activity and introduction of hormones.
Studies show that environmental enrichment and insertion of neuroprotective hormones allow
the growth and survival of neurons, specifically within the dentate gyrus of the hippocampus.
The following paragraphs will examine these methods of promoting neurogenesis and how they
relate with previous research on HIV-1.
Physical activity is known to be one of the most efficient methods for promoting
neurogenesis in the dentate gyrus of the hippocampus. Physical activity is a form of
environmental enrichment which is known to stimulate several cognitive processes.
Environmental enrichment includes proper nourishment, objects to interact with, and social
settings, all of which incorporate physical activity as a prominent component. One study
examining mice with historically poor levels of neurogenesis found that mice kept in enriched
environments had 67% more neurons and 2x as many proliferating cells in the dentate gyrus
compared to mice in standard housing (Kempermann, Brandon, and Gage, 1998). Behavioral
tests showed that these neuronal changes led to improvements in water maze performance, open
field tests, and rotarod times as a result of the enriched environment. Another study, performed
on the elderly, found that aerobic fitness correlated with hippocampus volume (Erikson et al.,
2009). In addition, the patients with increased levels of aerobic fitness had better spatial memory,
correlating with their hippocampus size. More studies examining aerobic activity have occurred
in stroke patients. Findings indicate that exercise can increase brain-derived neurotrophic factors
(BDNF) which promote survival, growth, and differentiation of neurons (El-Tamawy, 2014).
Exercise also decreases growth inhibitory proteins allowing for enhanced axonal development
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and recovery (Papadopoulos, 2002). These studies show the structural changes in neurons of
stroke patients as the result of physical activity. Exercise has the power to increase angiogenesis
in the hippocampus (Kleim and Jones, 2008), enhance vascular growth (Ma, Qiang, and He,
2013), and boost cerebral blood flow (Tian, Zhang, and Tian, 2013) assisting in stroke recovery.
However, most research still rests on the role that BDNF plays in stimulating neurogenesis (Liu
and Nusslock, 2018). After exercise, proteins secreted from muscles cross the blood brain barrier
stimulating the release of BDNF (Wrann et al., 2013). BDNF then binds with tropomyosin
receptor kinase B in the hippocampus making neuronal synapses more plastic. Furthermore, in
BDNF knockout mice, studies have shown reduced levels of proliferation, differentiation, and
migration of neurons compared to wild type mice (Lee, Duan, Mattson, 2002). These effects are
seen in mice which, after injection of skeletal muscle endurance factors, have elevated levels of
hippocampal neurogenesis and spatial memory (Kobilo, Yuan, and van Praag, 2010). Therefore,
exercise has the capability to incite neurogenesis leading to a wide range of cognitive
improvement, the most essential being an increase in BDNF activation which increases
proliferation and plasticity of neurons.
Hormones are another factor that influences neurogenesis. For example, the thyroid
hormone impacts neurogenesis in the dentate gyrus. Hypothyroidism leads to a 30% reduction in
number of proliferating cells, poor dendritic arborization (Montero-Pedrazuela, 2006), greater
number of immature cells, and smaller size of the granule layer in rodents (Ambrogini et al.,
2005). Furthermore, hypothyroid rats showed depressive tendencies, which returned to normal
with the introduction of thyroid hormones (as did the rate of neurogenesis and dendritic
arborization) (Montero-Pedrazuela, 2006). One review also displayed the effects that adrenal and
gonadal hormones have on neurogenesis (Galea et al., 2013). Results suggest that chronic stress
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can have negative effects on dendrite length (Galea et al., 1997), spine density (Magarinos and
McEwen, 1995), synaptic plasticity (Muller et al., 2011), and rate of neurogenesis (Czeh et al,
2002) as a result of the continuous release of stress related adrenal hormones. Gonadal hormones
such as androgens and estrogens also seem to play a large role in neuronal proliferation, cell
survival, and the resulting cognitive performance (Galea et al., 2013). Thus, both adrenal and
gonadal hormones can affect neurogenesis. These are a few examples showing the power of
hormones over cognition, but for the sake of this paper, we would like to focus specifically on
the hormone S-equol.
S-equol is a phytoestrogen produced by gut microbiota as an intestinal bacterial
metabolite that shows protective and restorative effects for neurons. HIV-1 appears to cause
microbial imbalance in the gut (Hamad et al., 2018), so a boost in the active metabolite involved
in digestion of soy may lead to therapeutic improvements in HIV-1 (Setchell et al., 1984). Sequol is shown to activate estrogen receptor β (Zhao, Dahlman-Wright, and Gustafsson, 2008)
which has implications in the improvement of ovarian function (Hegele-Hartung et al., 2004),
fight against inflammation (Leventhal et al., 2006), and regulation of prostate growth (Norman,
et al., 2006). The following studies have all examined the effects of s-equol treatment on HIV-1.
Moran and colleagues found that S-equol treatment improved sustained attention to the level of
controls and preserved cognitive function in transgenic rats (2019). These results were expedited
in prepulse inhibition tasks, signal detection operant tasks, and visual distractor tasks when
treatment was provided early in the HIV-1 infection process (McLaurin, 2019). S-equol was also
shown to prevent and restore synaptic loss in HIV-1 infected rats exposed to cocaine by
activating the estrogen receptor β (Bertrand et al., 2015). Therefore, S-equol shows the potential
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to act through neurorestorative and neuroprotective effects to mitigate the neurodegeneration and
cognitive decline seen in HIV-1 infected individuals.
The final step in this comprehensive introduction is to define the relationship between
HIV-1 and neurogenesis. Specifically, the role that previously discussed neurotoxins play in
neurogenesis and their attenuation through exercise, as well as the direct results of HIV-1/HAND
on neurogenesis. Initial results from Fitting and colleagues found that the introduction of
neurotoxin gp120 into the hippocampus decreased the number of neurons in the CA2 and CA3
regions (2008). Lee and colleagues then found that gp120 reduces proliferation of new neurons
and leads to poor dendritic development in rodents modeling HIV-1 (2011). Voluntary wheel
running attenuated these deficiencies and restored numbers of progenitor cells and dendritic
complexity in these animals. In addition, neurotoxins like Vpr have the ability to infect
mitochondria which decrease the membrane potential activating ATP synthesis and preventing
axonal growth in rodents modeling HIV-1 (Kitayama et al., 2008). Other research examines the
roles of cytokines. The infection of macrophages with viral HIV-1 decreases neural proliferation
and astrocyte differentiation by preventing the function of regulatory cytokines (Peng et al.,
2008). As discussed previously, SDF-1 is expressed in neurons and astrocytes in the dentate
gyrus. SDF-1 shows the capacity for “excitation-neurogenesis” which regulates the proliferation
of neuronal progenitor cells (Deisseroth et al., 2004). However, the HIV-1 virus has antagonistlike features with SDF-1 and binds to its receptor, CXCR4, preventing the regulation of
neurogenesis (Tran and Miller, 2005). As a result, HIV-1 alters the function of SDF-1
preventing the growth of new neurons. Taken together, these results show how HIV-1 can
prohibit neurogenesis which may be the cause of cognitive decline.
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The previous sections have outlined HIV-1 infection, HAND, and the restorative power
of neurogenesis. The review of neurotoxins displays the neurodegenerative influence of HIV-1
from gp120, Vpr, and SDF-1 dysfunction. We also reviewed the wide range of impairment as a
result of HIV-1 infection that lead to HAND. These impairments circle around brain atrophy and
so therapy has focused on neurogenesis to alleviate these deficiencies. The growth of new
neurons is negatively affected from HIV-1 infection, but may be restored through exercise or the
introduction of hormones. The present study expands on these ideas and looks to evaluate how
HIV-1 affects neurogenesis in rodents after exposure to voluntary exercise and S-equol.
HYPOTHESIS
The purpose of this study is to determine the effects of physical activity and S-equol on
neurogenesis within the dentate gyrus of HIV-1 transgenic rats. I hypothesize that voluntary
exercise will increase proliferation of neurons and have a positive effect on neurogenesis. I also
theorize that the neuroprotective aspects of S-equol will allow for the continued differentiation
and survival of newly born neurons which will show greater levels of neurogenesis. These two
separate studies may display therapeutic benefits that could alleviate the cognitive impairment in
rodents modeling HIV-1 by increasing rates of neurogenesis and preventing the
neurodegenerative aspects associated with the disease.
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METHODS
This study seeks to understand the roles that physical activity and the introduction of sequol play in increasing the rate of neurogenesis in rodents modeling HIV-1. We will evaluate
the methods of infecting our rat models, staining techniques used to determine levels of
neurogenesis, and the procedures used in the study.
This experiment uses HIV-1 transgenic rats to investigate how each condition affects
neurogenesis. Transgenic rats are those in which foreign DNA has been introduced before birth.
In our case, we have added parts of the human genome with HIV-1 that allow for proper
infection, but no replication, of the virus. The transgenic model accurately shows HIV-1
impairment without the potential of spreading the disease to humans or control samples.
Vigorito, Connaghan, and Chang provide a detailed procedure of the infection of the HIV-1
transgenic rat (2015). Removal of gag and pol genes from the HIV-1 virus leads to the creation
of a non-infectious provirus. This provirus is then injected into a fertilized egg, infecting one of
the two alleles of the zygote. Once this transgenic animal develops and is mated, the resulting
offspring has a 50% chance of being either HIV-1 transgenic or wild-type F344 controls. If HIV1 transgenic, the rodent will still contain the genes that lead to inflammation and neurotoxic
effects in the brain, even though the gag and pol genes have been removed. The resulting HIV-1
transgenic rat continues to express HIV-1-mediated deficits throughout its lifetime, providing an
opportunity to examine effects on neurogenesis.
All rats in the current experiments were pair-housed in AAALAC-accredited facilities
using guidelines established by the National Institute of Health. The targeted environmental
conditions were a 12h:12h light/dark cycle with lights on at 700 h (EST), 21°± 2°C, and 50% ±
10% relative humidity. Animals had ad libitum access to rodent chow (2020X (Harlan Teklad,
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Madison, WI)) and water. HIV-1 Tg and F344/N rat were obtained from Harlan Laboratories
(Indianapolis, IN). These experiments were approved by the Animal Care and Use Committee
(IACUC) at the University of South Carolina (federal assurance number: # D16-00028).
To investigate levels of neurogenesis, we will be using immunohistochemical tags to
highlight doublecortin proteins (DCX) found in our recently born neurons. We will only be
examining the dentate gyrus of the left hippocampus to inspect the neurons that have migrated
through the SGZ toward the granule layer. We will also investigate the location of growth, as
some research indicates differences dependent on the dorsal or ventral blade of the dentate gyrus
(Snyder et al., 2009). This distinction is shown in Figure 1. Furthermore, DCX has been shown
to be heavily involved with the migration of neurons (Flanagan et al., 1999) and is not visible
during the proliferation of stem cells to D cells (Seri et al., 2004). This migration period lasts for
approximately 3 weeks (Steiner et al., 2004) and occurs between 2 and 8 weeks after the neuron
is born (Kempermann et al., 2004). As a result, DCX+ neurons must be born in the last few
weeks and staining for the protein will indicate effective neurogenesis. We used mouse
antibodies to tag DCX proteins and effective staining techniques to highlight the antibodies, as
seen in Figure 2. Therefore, DCX provides a reliable method to visualize the effects of
neurogenesis in the dentate gyrus and will be used to study the impact of physical activity and sequol.

18

LAPOINTE

Dorsal

Ventral

Figure 1: This picture shows the dorsal and ventral blades of the dentate gyrus. Neurons were
recorded by location based on this criteria to distinguish where a majority of the new neurons
were grown. New neurons are distinguished by their dark coloring.
Step 1: Primary mouse
antibody added which
attaches to the Doublecortin
protein.

Step 3: Vectastain ABC
reagent solution and
diaminobenzidine
working solution added
which tagged the
secondary antibody.

Step 2: Secondary horse antimouse antibody added
which attaches to the
primary mouse antibody.

Step 4: Viewer can see
highlighted tags when
viewing neurons under a
microscope

Figure 2: This shows the ABC DAB procedure and how antibodies are used to tag DCX
proteins and highlight new neurons. By highlighting DCX proteins we were able to visualize
the effects of neurogenesis.
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This procedure occurred in a two-step process to measure the effects of physical activity
and, separately, the effects of s-equol. The first step was to understand how wheel running
increased proliferation of neurons in the dentate gyrus within the HIV-1 transgenic rat
hippocampus. 72 animals representing both sexes were divided into groups based on genotype
and running condition. The four groups consisted of a F344 control sedentary group (n=19),
F344 running group (n=18), HIV-1 transgenic sedentary group (n=16), and HIV-1 transgenic
running group (n=19). If in the running condition, animals ran for one hour every day until the
running distance plateaued, which took approximately 15-21 weeks. The sedentary animals were
still placed in the running wheel for an equal amount of time, but the wheel was locked to
prevent running. Animals were sacrificed once running distance stabilized, and the hippocampus
was coronally sectioned into approximately ten 500µm slices. Every other slice was stained for
DCX, leading to 4-5 slices per hippocampus running from the anterior to posterior hippocampus.
A Nikon Eclipse E800 microscope was used to examine these brain slices. The
StereoInvestigator (MBF Biosciences) Program was used to record the location and number of
DCX+ neurons found in the dentate gyrus of the left hippocampus. Data was analyzed using the
IBM SPSS program. We used t-tests (p=.05) and two-way ANOVA’s to compare differences
between experimental conditions and their respective controls. We expect that physical activity
will increase DCX+ counts.
The second study examined how the injection of s-equol could increase neurogenesis
within the dentate gyrus. The animals were divided into 4 groups with sex considered leading to
a control group of F344 rats (n=16), a F344 group receiving s-equol treatment (n=18), HIV-1
transgenic rats receiving a placebo (n=16) and HIV-1 transgenic rats administered with s-equol
(n=19). Starting at PD 28, HIV-1 transgenic and control animals began receiving oral pellets
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with either 0.2 mg of s-equol for the experimental condition or sucrose for the control groups.
Previous research indicates that 0.2 mg of s-equol was the most effective therapeutic level for the
preservation of cognitive function (Moran et al., 2019). Oral doses were given daily through PD
90 and then animals were sacrificed. Similar DCX and statistical analysis methods were used as
the physical activity condition to investigate levels of neurogenesis. We expect that s-equol will
raise DCX+ counts in the animals receiving the therapeutic treatment.
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RESULTS
This study evaluated whether physical activity or s-equol could increase levels of
neurogenesis in HIV-1 transgenic rats. We ran t-tests and ANOVA’s between the conditions to
evaluate differences between the average counts of DCX+ neurons. Unfortunately, we only
found a few significant results for physical activity and the administration of s-equol. The
following paragraphs examine the results from both induced physical activity and s-equol
treatment.
The first experiment evaluated the effect of physical activity on DCX+ cell counts. We
found significant results from gender differences and location of new neurons. A t-test showed
that males (M=258.61, SD=91.27) compared to females (M=144.69, SD=60.86) had
significantly more DCX+ neurons t(69)=6.170, p=0.034 as shown in Figure 3. This result was
supported by a two-way ANOVA that failed to show an interaction F(1,67)=2.673, p=0.107, but
showed significant results on the individual level for both gender differences F(1,69)=41.236,
p=0.000, and genotype effects F(1,69)=4.809, p=0.032. In addition, significant effects were also
found in HIV-1 transgenic and control subjects based on the location of new neurons on the
dentate gyrus, although no interactions were found. Evidence from HIV-1 models indicates that
more neurons are grown on the ventral blade compared to the dorsal blade F(1,69)=13.391,
p=0.001. The same result is found in control animals F(1,69)=7.096, p=0.010. These findings are
shown in Figure 4. These results show significant differences based on sex and location of new
neurons as a result of physical activity.
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Sex Differences in Physical Activity Study
400

Average DCX+ counts

350
300
250
200
150
100
50
0
Males

Females
Experimental Condition

Figure 3: This shows the sex differences in total neurons recorded across genotype and running
condition. Males (M=258.61, SD=91.27) had almost twice as many neurons compared to females
(M=144.69, SD=60.86), p=0.034.

Location of DCX+ neurons
200
Dorsal

180

Ventral

Average DCX+ counts

160
140
120
100
80
60
40
20
0
F344

HIV-1
Genotype

Figure 4: This graph shows the difference between total neurons counted between the dorsal and
ventral blades of the dentate gyrus. There were significantly more neurons grown on the ventral
blade in control animals, F(1,69)=7.096, p=0.010, and in HIV-1 transgenic animals
F(1,69)=13.391, p=0.001.
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There appeared to be some impairment in DCX+ counts in HIV-1 transgenic animals, but
all of the results were non-significant. In HIV-1 transgenic runners (M=185.63, SD=75.15)
compared to F344 runners (M=231.83, SD=106.91) the result was non-significant t(35)=1.528,
p=0.136. This distinction was also seen in the sedentary animals, with no differences seen in total
counts between sedentary F344 animals and sedentary HIV-1 transgenic animals, t(33)=0.791,
p=0.389. An ANOVA run between all four conditions found no interaction or significance of
genotype and running condition F(1,68)=0.187, p=0.666. The total cells counted within the
control and HIV-1 transgenic groups can be seen in Figure 5. These results show that genotype
did not significantly impair cell counts and physical activity did not successfully increase
neurons to counteract this impairment.

Total DCX+ Counts in Physical Activity Study
350
F344

Average DCX+ counts

300

HIV-1

250
200
150
100
50
0
Sedentary

Running
Exercise Condition

Figure 5: This graph shows the total cell counts for all four of our conditions between
genotype and running condition. There were no significant results based on running group or
genotype. An ANOVA between the four conditions found no interaction or significance
between running condition and genotype, F(1,68)= 0.187, p=0.666.
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One goal of the first study was to investigate if HIV-1 transgenic running rodents had
increased neurogenesis compared to their sedentary counterparts. Out of the 35 HIV-1 transgenic
animals, those exposed to running (M=185.63, SD=75.15) compared to sedentary animals
(M=180.56, SD=84.20) did not show a significant difference in levels of neurogenesis,
t(33)=0.188, p=0.766., as shown in Figure 5. For the dorsal blade, the running group (M=72.89,
SD=31.28) compared to the sedentary group (M=71.19, SD=39.38) was not significantly
different in cell counts, t(33)=0.143, p=0.887. Finally, there was no difference t(33)= 0.190,
p=0.850, in the ventral blade between the running group (M=112.73, SD= 50.84) and sedentary
group (M=109.38, SD=53.49). These results suggest that there were no significant differences in
cell counts within the HIV-1 animals exposed to running and sedentary conditions.
There were similar null effects of physical activity even when evaluating only the control
condition. There were 37 control animals tested, and those exposed to running (M=231.83,
SD=106.91) compared to sedentary (M=207.21, SD=110.30) did not show a significant
difference in levels of neurogenesis, t(35)=0.689, p=0.495. These results are also shown in
Figure 5. There were also no differences found in the dorsal blade where the running condition
(M=100.78, SD=52.27) and sedentary condition (M=84.05, SD=54.35) did not show a
significant change in neurogenesis levels t(35)=0.953, p=0.347. In addition, the ventral blade
showed that runners (M=131.06, SD=59.23) versus sedentary animals (M=123.68, SD=59.43)
did not have a difference t(35)=0.378, p=0.708. Although the running animals consistently have
greater counts, none of their results are significantly different than their control counterparts.
The average total cell counts from each of the four conditions as a result of physical
activity can be seen in Figure 5. Results from the dorsal blade are seen in Figure 6, and the levels
of neurogenesis in the ventral blade are found in Figure 7. A Levene’s Test was run on total cell
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counts to explore equality of variance and found that F(3,68)=.710, p=0.549 indicating
homogeneity of variance between the four groups. Levene’s tests was also conducted for every ttest, and all results indicate equal variances between any two given conditions. Neurogenesis
levels were consistently higher in control groups and running groups, but the DCX+ counts were
not significantly different than their counterparts. Significant differences were seen with males
having more counts than females, and more DCX+ neurons found on the ventral blade than on
the dorsal blade.

Dorsal Blade DCX+ Counts in Physical Activity
Study
F344 HIV-1
Average DCX+ coints

160
140
120
100
80
60
40
20
0
Sedentary

Running

Experimental Condition
Figure 6: We found no significant differences in cell counts on the dorsal blade of the dentate
gyrus based on experimental condition.
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Average DCX+ counts

Ventral Blade DCX+ Counts in Physical Activity
F344 HIV-1
Study
200
150
100
50
0
Sedentary

Running

Experimental Condition

Figure 7: This figure shows the average cell counts on the ventral blade of the dentate
gyrus. There were no significant differences between groups and the resulting number of
counts. Although the controls appear to have more counts, the result was not significantly
different.

The second experiment evaluated the effect of oral administration of s-equol on
neurogenesis. Without considering genotype, we found very similar effects regardless of
treatment or placebo doses. Animals receiving s-equol (M=91.89, SD=42.25) compared to a
placebo (M=91.66, SD=43.47) did not lead to differences in neurogenesis t(64)=0.022, p=0.817.
An ANOVA considering genotype and treatment groups found no interaction F(1,65)=0.497,
p=0.484, nor a difference in either condition in DCX+ cell counts One significant result came
from an ANOVA analyzing the location of neurons receiving different treatment in the control
animals. There was an interaction between location on the dentate gyrus and treatment group
F(1,64)=9.227, p=0.003 within the controls as shown in Figure 8. No significant results were
found when looking at the same conditions in the HIV-1 transgenic animals F(1,66)=0.971,
p=0.328. Furthermore, there was no difference in cell counts as a result of genotype t(67)=1.571,
p=0.323.
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Interaction between Treatment and Location
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Figure 8: This graph of the control animals shows the interaction between treatment group
and location of neuronal growth, F(1,64)=9.227, p=.003. Dorsal counts were much higher
with the administration of s-equol compared to placebo doses. Standard deviation is mapped
in red for s-equol treatment and grey for placebo. We did not find the same interaction in the
HIV-1 transgenic group F(1,66)=0.971, p=0.328.

The main objective of the second experiment was to show that the protective aspects of sequol spurred neurogenesis in the HIV-1 animals more than administration of the sucrose
placebos. T-tests revealed that in the 35 HIV-1 transgenic animals, consuming s-equol
(M=95.00, SD=49.17) compared to sucrose pellets (M=78.65, SD=29.27) did not significantly
alter total DCX+ cell counts t(33)=1.237, p=0.062. as shown in Figure 9. In the dorsal blade, sequol animals (M=44.05, SD=24.76) compared to control animals (M=38.19, SD=18.26) also
did not lead to significant differences t(33)=0.784, p=0.618. Finally, the ventral blade did not
show significant differences t(33)=0.491, p=0.289, in the s-equol group (M=44.37, SD=22.08)
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compared to the placebo controls (M=41.13, SD=15.73). There appear to be no effects of s-equol
treatment on DCX+ neurons in HIV-1 transgenic animals.
In the control animals, s-equol treatment still did not show any main effects of increasing
rates of neurogenesis. We found that s-equol treatment (M=95.55, SD=42.33) compared to
sucrose pellets (M=100.81, SD=50.70) did not significantly change total neurogenesis levels
t(32)=0.329, p=0.847. The dorsal blade showed the same null effects t(32)=0.779, p=0.937, as sequol treatment (M=46.50, SD=24.41) was not different than placebo treatment (M=53.38,
SD=27.08). In the ventral blade, s-equol treatment (M=49.06, SD=20.69) compared to controls
(M=51.38, SD=25.09) were not significantly different t(32)=0.295, p=0.650. As a result, s-equol
does not seem to increase neurogenesis levels compared to animals receiving a sucrose pellet
placebo. It is interesting to note that the control animals had more DCX+ counts compared to sequol treated animals in all three experiments, although the effects were not significantly
different.
Total DCX+ cell counts in the four conditions can be seen on Figure 9. Dorsal counts and
ventral counts can be seen on Figure 10 and Figure 11, respectively. There were no gender
effects for this experiment t(67)=0.847, p=0.128. We ran a Levene’s homogeneity test and found
that all four conditions had similar variances F(3,65)=0.533, p=0.661. The variance between all
conditions was also equal when comparing any two conditions. The one significant effect was
found in control animals who had a greater number of counts on their dorsal blade after taking sequol pellets compared to animals who received a placebo. It appears as though there are limited
effects on neurogenesis with the introduction of s-equol on HIV-1 transgenic animals or their
control counterparts.
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Figure 9: Total counts between all conditions based on treatment group and genotype
conditions. We found no significant differences between groups. It is interesting to note that
the placebo F344 rat had the highest number of counts, although the result was not
significant.
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Figure 10: This graph shows the average neurons counted in the dorsal blade within each
condition. There were no significant differences between groups.
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Figure 11: This result shows the DCX+ counts from the ventral blade as a result of s-equol
and placebo doses. There were no significant differences between the four conditions.
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DISCUSSION
This study investigated the therapeutic potential of physical activity and s-equol in the
restoration of impaired neurogenesis found in the HIV-1 transgenic rodent. We hoped that
physical activity would increase rates of neurogenesis by activating BDNF proteins and
stimulating plastic functions of neurons. In addition, we anticipated an increase in neurogenesis
with the introduction of s-equol, a hormone shown to include restorative and protective features
for neurons. We found limited significant differences between groups, but there were still a few
vital distinctions to be discovered. There were also surprising nonsignificant results which
should be further examined.
It appears as though physical activity has a limited impact on increasing rates of
neurogenesis in the HIV-1 transgenic rat. There were no significant results between the running
and sedentary groups in either the control or HIV-1 groups. This may be due to a lack of total
running time, as the animals only ran for one hour per night, which may not have been enough
time to differentiate from their sedentary counterparts. Future research should investigate
differing amounts of exercise as a therapeutic for cognitive dysfunction. In addition, we did not
find any significant impairment in neurogenesis as a result of HIV-1 infection. HIV-1 transgenic
rats matched their control counterparts in cell counts regardless of running or sedentary
conditions. This result is surprising, and goes against a majority of research that suggests HIV-1
inhibits neurogenesis (Tran and Miller, 2005; Fitting et al., 2008). However, we did find some
significant differences in gender and location of new neurons as a result of physical activity.
Males had almost 2x as many DCX+ neurons grown, not considering genotype conditions. We
suspect that this difference is due to sex-dependent hormones such as estrogen that play an active
role in neurogenesis (Bowers, Waddell, and McCarthy, 2010; Duarte-Guterman et al., 2015). Our
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results support previous understanding that indicates males have greater levels of neurogenesis in
the dentate gyrus. The other significant finding from this study was the increase in DCX+
neurons found on the ventral blade compared to the dorsal blade of the dentate gyrus. Although
there is little research done on the difference between the two blades, it is possible for the two
areas to have different functionalities. We found significantly higher counts in the ventral
regions, which is opposite of Tanti and colleagues, who found that environmental enrichment
significantly increases growth in the dorsal dentate gyrus (Tanti et al., 2012). In addition,
Ambrogini and colleagues found that enrichment leads to more recently grown neurons in the
anterior half of the dentate gyrus compared to the posterior half (Ambrogini et al., 2000). It is
clear that there is not a known area of increased neurogenesis within the dentate gyrus as a result
of physical activity and future studies should focus on the location of recently grown neurons as
well as the functionality of increased neuronal growth in that specific area.
We also did not find significant results in the second study, suggesting that administration
of s-equol may not affect neurogenesis. The null result of s-equol treatment was found in both
HIV-1 transgenic animals and controls. One significant finding was based on an interaction
between treatment and growth of new neurons in the control animals. We found that adding sequol treatment led to a large spike in growth within the dorsal blade of the dentate gyrus.
Meanwhile, there was no difference in the ventral blade with the introduction of s-equol. This
evidence supports a previous study by Suzuki and colleagues who found that estradiol
significantly increases neurogenesis in the dorsal region of the subventricular zone (2006).
Future research should investigate the cause of this specific growth as well as the functionality of
increased neuronal growth in the dorsal regions. As we alluded to in the previous section, there
appears to be varying levels of growth within different regions of the dentate gyrus that need to
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be further explored. There is also a very interesting non-significant result that needs to be
investigated. The difference between HIV-1 animals receiving s-equol versus placebo was very
close to significance, recording p=0.062, suggesting that s-equol did attenuate some of the
impairment seen from the HIV virus. This was the closest comparison to significance, so it is
possible that the hormone restored some levels of neurogenesis in the transgenic animals.
However, it appears as though s-equol did not significantly increase neurogenesis in the controls.
One of the largest issues with this study was the methodology involved in recording
neurogenesis levels. We used DCX tags to highlight proteins in newborn neurons, but found that
the tags also tended to look similar to random artifacts and splotches under the microscope. The
counting was done manually, so it was up to the experimenter to determine if the highlighted
object was an artifact or a neuron. This led to excessively high variance between counts making
significant results difficult to come by. Other studies have used BrdU staining techniques which
may be a more reliable measure. Experiments that continue to use DCX procedures need to
ensure clean staining of brain slices and determine a consistent and accurate way to count the
tagged neurons.
In conclusion, we fail to reject the null hypothesis. We found no compelling evidence to
suggest that physical activity, nor administration of s-equol, can attenuate the inhibited
neurogenesis seen as a result of HIV-1 infection. These null effects were also seen in control
animals, as none of the relevant experimental conditions displayed significant differences in
DCX+ cell counts. These studies found significant effects based on sex and the location of
recently grown neurons which should be investigated further.
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